Garrett Hamontree

Garrett joined the Visionary Venture Fund in 2017 as an Associate and now serves as a Principal for the Fund where he performs valuation, diligence, and market potential analysis, as well as assisting in negotiating and executing transactions. Additionally, Mr. Hamontree assists with ongoing operations and corporate strategy for Visionary portfolio companies, including as a Board Observer for Equinox, TearClear, Tear Film Innovations, and Orasis Pharmaceuticals. Prior to joining Visionary, Mr. Hamontree was CEO, President, and Board Member of Bridgemark, a privately held company, where he invested private equity and debt in a variety of private market transactions to grow operations and assets across the United States. At Bridgemark, Mr. Hamontree built a team of seasoned subject matter experts from various backgrounds to help source deals and to perform due diligence on potential transactions. Prior to Bridgemark, Mr. Hamontree was a project manager for Chevron leading major capital projects. Mr. Hamontree graduated from Vanderbilt University with a Bachelor of Engineering and from the University of Southern California’s Marshall School of Business with an MBA in Finance and Data Science.